FindTrial
Sign In

18F-FAZA

OTHER5 trials

Sponsors

AHS Cancer Control Alberta, University of Aarhus, University Health Network, Toronto

Conditions

Cancer of the Head and NeckCell HypoxiaHypoxic TumoursLocally Advanced Pancreatic AdenocarcinomaLung NeoplasmPancreatic Adenocarcinoma Non-resectableSarcomaUnresectable Pancreatic Cancer

Unknown Phase

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA
WithdrawnNCT00756691
AHS Cancer Control AlbertaHypoxic Tumours
Updated: 2017-11-14
Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy
NCT00765986
AHS Cancer Control AlbertaCell Hypoxia, Lung Neoplasm
Start: 2008-10-31End: 2015-10-31Target: 30Updated: 2014-10-03
DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)
CompletedNCT01017224
University of AarhusCancer of the Head and Neck
Start: 2009-11-30End: 2012-05-31Updated: 2012-05-14
FAZA PET/MRI Sarcoma
Active, not recruitingNCT03418818
University Health Network, TorontoSarcoma
Start: 2018-03-27End: 2028-10-01Target: 70Updated: 2026-03-06
FAZA PET/MRI Pancreas
Active, not recruitingNCT04395469
University Health Network, TorontoLocally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Non-resectable, Unresectable Pancreatic Cancer
Start: 2021-05-18End: 2027-03-01Updated: 2026-03-05

Related Papers

Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).
2020-08-1425 citations